2007
DOI: 10.1016/j.jocn.2005.11.011
|View full text |Cite
|
Sign up to set email alerts
|

The effect of metoclopramide on gastric emptying in traumatic brain injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
33
0
7

Year Published

2008
2008
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(42 citation statements)
references
References 15 publications
1
33
0
7
Order By: Relevance
“…It highlights the need to regularly reappraise the need for adjuvant nutritional support by means of nasoenteral tubes as these are distressing to patients. Metaclopramide was used in all patients, with no adverse complications associated with its use in agreement with other reported studies, even though its value remains somewhat contentious (6,15,16).…”
Section: Discussionsupporting
confidence: 88%
“…It highlights the need to regularly reappraise the need for adjuvant nutritional support by means of nasoenteral tubes as these are distressing to patients. Metaclopramide was used in all patients, with no adverse complications associated with its use in agreement with other reported studies, even though its value remains somewhat contentious (6,15,16).…”
Section: Discussionsupporting
confidence: 88%
“…Rationale: Adding prokinetic agents such as erythromycin or metoclopramide has been shown to improve gastric emptying and tolerance of EN but has resulted in little change in clinical outcome for ICU patients. A total of 8 RCTs that met our inclusion criteria 130 137 using metoclopramide and 1 combining erythromycin with metoclopramide were reviewed by meta‐analysis. No difference was found in terms of mortality or infection.…”
Section: Monitoring Tolerance and Adequacy Of Enmentioning
confidence: 99%
“…A total of 8 randomized controlled trials using metoclopramide and 1 trial combining erythromycin with metoclopramide were reviewed by meta‐analysis. The use of prokinetic agents was not found to make a difference in terms of mortality or infection 42 . ‐ 49 Erythromycin has been associated with undesirable effects, including cardiac toxicity, tachyphylaxis, and bacterial resistance, and should be used cautiously with monitoring.…”
Section: Section 9 Complication Avoidance and Error Reportingmentioning
confidence: 99%